These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2125294)

  • 1. Conjugation of interferon-gamma to antigen enhances its adjuvanticity.
    Heath AW; Playfair JH
    Immunology; 1990 Nov; 71(3):454-6. PubMed ID: 2125294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
    Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
    Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of delayed-type hypersensitivity and interferon-gamma to Candida albicans and anti-hen-egg white lysozyme antibody as phenotypic markers of enhanced bovine immune response.
    Heriazon A; Yager JA; Sears W; Mallard BA
    Vet Immunol Immunopathol; 2009 May; 129(1-2):93-100. PubMed ID: 19155071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant gamma interferon is a potent adjuvant for a malaria vaccine in mice.
    Playfair JH; De Souza JB
    Clin Exp Immunol; 1987 Jan; 67(1):5-10. PubMed ID: 3113784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of DTH and IgE responses by IL-4 and IFN-gamma in immunized mice given pertussis toxin.
    Mu HH; Sewell WA
    Immunology; 1994 Dec; 83(4):639-45. PubMed ID: 7875744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(gamma-glutamic acid) nanoparticles as an efficient antigen delivery and adjuvant system: potential for an AIDS vaccine.
    Wang X; Uto T; Akagi T; Akashi M; Baba M
    J Med Virol; 2008 Jan; 80(1):11-9. PubMed ID: 18041033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with an interferon-gamma-gp120 fusion protein induces enhanced immune responses to human immunodeficiency virus gp120.
    McCormick AL; Thomas MS; Heath AW
    J Infect Dis; 2001 Dec; 184(11):1423-30. PubMed ID: 11709784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant-free IgG responses induced with antigen coupled to antibodies against class II MHC.
    Carayanniotis G; Barber BH
    Nature; 1987 May 7-13; 327(6117):59-61. PubMed ID: 3472080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of IFN-gamma in delayed-type hypersensitivity mediated by Th1 clones.
    Fong TA; Mosmann TR
    J Immunol; 1989 Nov; 143(9):2887-93. PubMed ID: 2530282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of delayed-type hypersensitivity by pertussigen or cyclophosphamide with release of different lymphokines.
    Sewell WA; de Moerloose PA; Hamilton JA; Schrader JW; Mackay IR; Vadas MA
    Immunology; 1987 Aug; 61(4):483-8. PubMed ID: 3127325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine lymph node antigen presenting cells are the main source of interleukin-6 in the initiation of delayed-type hypersensitivity.
    Ulrich P; Vohr HW
    Eur Cytokine Netw; 1996 Sep; 7(3):401-7. PubMed ID: 8954184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
    Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
    Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD40 antibody as an adjuvant induces enhanced T cell responses.
    Carlring J; Barr TA; McCormick AL; Heath AW
    Vaccine; 2004 Sep; 22(25-26):3323-8. PubMed ID: 15308355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-gamma attenuates antigen-induced overall immune response in the airway as a Th1-type immune regulatory cytokine.
    Nakagome K; Okunishi K; Imamura M; Harada H; Matsumoto T; Tanaka R; Miyazaki J; Yamamoto K; Dohi M
    J Immunol; 2009 Jul; 183(1):209-20. PubMed ID: 19542432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel role for neutrophils as a source of T cell-recruiting chemokines IP-10 and Mig during the DTH response to HSV-1 antigen.
    Molesworth-Kenyon SJ; Oakes JE; Lausch RN
    J Leukoc Biol; 2005 Apr; 77(4):552-9. PubMed ID: 15629884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte recruitment in delayed-type hypersensitivity. The role of IFN-gamma.
    Issekutz TB; Stoltz JM; vd Meide P
    J Immunol; 1988 May; 140(9):2989-93. PubMed ID: 3129506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced immunological tolerance against allograft rejection by oral administration of allogeneic antigen linked to cholera toxin B subunit.
    Sun JB; Li BL; Czerkinsky C; Holmgren J
    Clin Immunol; 2000 Nov; 97(2):130-9. PubMed ID: 11027453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen.
    Borges O; Silva M; de Sousa A; Borchard G; Junginger HE; Cordeiro-da-Silva A
    Int Immunopharmacol; 2008 Dec; 8(13-14):1773-80. PubMed ID: 18801462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amended recombinant cells (ARCs) expressing bovine IFN-gamma: an economical and highly effective adjuvant system.
    Gaertner FH; Babiuk LA; Mutwiri G; Armstrong JM; Griebel PJ
    Vaccine; 2009 Feb; 27(9):1377-85. PubMed ID: 19150640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity.
    Suzuki Y; Wakita D; Chamoto K; Narita Y; Tsuji T; Takeshima T; Gyobu H; Kawarada Y; Kondo S; Akira S; Katoh H; Ikeda H; Nishimura T
    Cancer Res; 2004 Dec; 64(23):8754-60. PubMed ID: 15574787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.